COURAGE CAPITAL MANAGEMENT LLC portfolio

Latest available portfolio: Q3 2026 · Holdings as of · Filed ·
$75.74MFull value: $75,744,000 · USD · 30 Sep 2026
in Form 13F holdings
See latest portfolio changes

Quarterly portfolio filings

Choose a quarter to see holdings and changes. Newer portfolio dates appear first.

Estimated additions and reductions require qualified adjacent-quarter disclosures and use filing-derived prices. A dash means unavailable; these estimates are not actual trade proceeds or costs.

Quarter Holdings SEC-reported value Est. additions Est. reductions Est. net Top Holdings Form Type Accepted by SEC
Q3 2026 18 $75,744,000 — — — BKLN, PHYS, FBTC, CXW, AAAU 13F-HR 16 Nov 2026, 17:28
Q2 2026 16 $67,312,000 — — — BKLN, CXW, PHYS, AAAU, FBTC 13F-HR 11 Aug 2026, 15:48
Q1 2026 14 $70,624,000 — — — BKLN, FBTC, PHYS, CXW, AAAU 13F-HR 14 May 2026, 16:30
Q4 2025 13 $72,356,000 — — — BKLN, FBTC, CXW, PHYS, AAAU 13F-HR 17 Feb 2026, 16:02
Q3 2025 14 $75,685,000 — — — FBTC, BKLN, CXW, PHYS, AAAU 13F-HR 12 Nov 2025, 10:18
Q2 2025 13 $67,804,000 — — — FBTC, BKLN, CXW, PHYS, AAAU 13F-HR 15 Aug 2025, 09:13
Q1 2025 12 $48,974,000 — — — BKLN, CXW, PHYS, FBTC, AAAU 13F-HR 14 May 2025, 11:38
Q4 2024 12 $48,458,000 — — — BKLN, CXW, FBTC, PHYS, AAAU 13F-HR 14 Feb 2025, 10:42
Q3 2024 11 $40,363,000 — — — BKLN, PHYS, CXW, AAAU, META 13F-HR 14 Nov 2024, 17:51
Q2 2024 12 $39,607,000 — — — BKLN, Coherus Biosciences Inc, CXW, PHYS, AAAU 13F-HR 14 Aug 2024, 18:08
Q1 2024 12 $34,525,000 — — — CXW, BKLN, Coherus Biosciences Inc, PHYS, AAAU 13F-HR 10 May 2024, 15:02
Q4 2023 11 $24,775,000 — — — Coherus Biosciences Inc, PHYS, Evolent Health Inc, AAAU, META 13F-HR 12 Feb 2024, 10:48
Q3 2023 12 $29,484,000 — — — Coherus Biosciences Inc, PHYS, Coherus Biosciences Inc, AAAU, META 13F-HR 08 Nov 2023, 16:48
Q2 2023 17 $36,431,000 — — — Coherus Biosciences Inc, PHYS, General Dynamics Corp, AAAU, META 13F-HR 14 Aug 2023, 16:50
Q1 2023 17 $41,711,000 — — — Coherus Biosciences Inc, General Dynamics Corp, AAAU, PHYS, BRY 13F-HR 15 May 2023, 10:49
Q4 2022 18 $35,596,000 — — — Coherus Biosciences Inc, Evolent Health Inc, AAAU, PHYS, MSFT 13F-HR 13 Feb 2023, 18:42
Q3 2022 18 $46,172,000 — — — Coherus Biosciences Inc, Evolent Health Inc, AAAU, CHRD, PDCE 13F-HR 14 Nov 2022, 14:14
Q2 2022 22 $60,837,000 — — — Coherus Biosciences Inc, Evolent Health Inc, CHK, WLL, CEIX 13F-HR 12 Aug 2022, 14:42
Q1 2022 34 $104,787,000 — — — Coherus Biosciences Inc, Evolent Health Inc, CHK, MSFT, GOOG 13F-HR 16 May 2022, 15:10
Q4 2021 38 $149,344,000 — — — Coherus Biosciences Inc, Evolent Health Inc, EXC, EVH, Evolent Health Inc 13F-HR 14 Feb 2022, 15:19
Q3 2021 40 $185,262,000 — — — Coherus Biosciences Inc, Evolent Health Inc, Evolent Health Inc, BCEI, EVH 13F-HR 15 Nov 2021, 12:27
Q2 2021 38 $166,575,000 — — — Coherus Biosciences Inc, Evolent Health Inc, CHRD, EVH, VEI 13F-HR 13 Aug 2021, 11:43
Q1 2021 40 $136,856,000 — — — CHRD, CHK, EVOLENT HEALTH INC, EVOLENT HEALTH INC, VTRS Restatement 18 May 2021, 11:45
Q4 2020 31 $81,069,000 — — — CHRD, Evolent Health Inc, VTRS, CCI, EVH 13F-HR 16 Feb 2021, 08:54
Q3 2020 28 $64,460,000 — — — Evolent Health Inc, MYL, CCI, EVH, Centene Corp. 13F-HR 16 Nov 2020, 10:31

Showing 1-25 of 52 filings.

Manager details and filing context
Latest 13F filing
Q3 2026 - 16 Nov 2026
Latest reported 13F value
$75,744,000
Largest 13F holdings
BKLN PHYS FBTC CXW AAAU SPY META AMZN GOOG IAU PNFP TSLA
+6 moreHCA UNH BE VST JNJ TYL
Manager location
Nashville, TN
Holdings Value
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .